Evidence map›Paper›PMID 36846419›Full record

ArticleLaryngoscope investigative otolaryngology2023

Comorbidity associated with worse outcomes in a population of limited cochlear implant performers.

Erika Lee, Justyn Pisa, Jordan Hochman

Abstract read
In one paragraph

Article in Laryngoscope investigative otolaryngology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erika LeeUniversity of Manitoba Faculty of Medicine Otolaryngology - Head and Neck Surgery Winnipeg Manitoba Canada.ORCID https://orcid.org/0000-0001-6310-0197
Justyn PisaUniversity of Manitoba Faculty of Medicine Surgical Hearing Implant Program, Department of Otolaryngology-Head and Neck Surgery Winnipeg Manitoba Canada.ORCID https://orcid.org/0000-0001-9551-9232
Jordan HochmanUniversity of Manitoba Faculty of Medicine Neurotologic Surgery, Department of Otolaryngology - Head and Neck Surgery Winnipeg Manitoba Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Most patients significantly benefit from cochlear implantation (CI). However, speech understanding varies widely, with a small proportion of patients demonstrating limited audiometric outcomes. While there are well-documented determinants of poor performance, there remains a cohort of patients that do not meet expected outcomes. Preoperative prognostication is desirable to manage expectations, ensure value of the intervention, and reduce risk. The objective of the study is to evaluate variables found within a single CI center's most limited functioning cohort following implantation. Methods: A retrospective review of a single CI program's cohort of (344 ears) patients implanted between 2011 and 2018 whose 1-year postimplantation AzBio scores fall 2 SDs below the mean was performed. Exclusion criteria includes skullbase pathology, pre/peri-lingual deafness, cochlear anatomic abnormalities, English as an additional language, and limited electrode insertion depth. Overall, 26 patients were identified. Results: The study population's postimplantation net benefit AzBio score is 18% compared to the entire program's 47% ( Conclusion: Within a cohort of limited-performing CI users, benefit tended to decrease with escalating number of comorbid conditions. This information may serve to inform preoperative patient counseling. Level of evidence: Level IV (evidence from a case control study).

Indexed as

audiologycochlear implantssensorineural hearing loss

Identifiers

PMID36846419
PMCPMC9948576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.